Efficiency of Xist-mediated silencing on autosomes is linked to chromosomal domain organisation.
BACKGROUND
X chromosome inactivation, the mechanism used by mammals to equalise dosage of X-linked genes in XX females relative to XY males, is triggered by chromosome-wide localisation of a cis-acting non-coding RNA, Xist. The mechanism of Xist RNA spreading and Xist-dependent silencing is poorly understood. A large body of evidence indicates that silencing is more efficient on the X chromosome than on autosomes, leading to the idea that the X chromosome has acquired sequences that facilitate propagation of silencing. LINE-1 (L1) repeats are relatively enriched on the X chromosome and have been proposed as candidates for these sequences. To determine the requirements for efficient silencing we have analysed the relationship of chromosome features, including L1 repeats, and the extent of silencing in cell lines carrying inducible Xist transgenes located on one of three different autosomes.


RESULTS
Our results show that the organisation of the chromosome into large gene-rich and L1-rich domains is a key determinant of silencing efficiency. Specifically genes located in large gene-rich domains with low L1 density are relatively resistant to Xist-mediated silencing whereas genes located in gene-poor domains with high L1 density are silenced more efficiently. These effects are observed shortly after induction of Xist RNA expression, suggesting that chromosomal domain organisation influences establishment rather than long-term maintenance of silencing. The X chromosome and some autosomes have only small gene-rich L1-depleted domains and we suggest that this could confer the capacity for relatively efficient chromosome-wide silencing.


CONCLUSIONS
This study provides insight into the requirements for efficient Xist mediated silencing and specifically identifies organisation of the chromosome into gene-rich L1-depleted and gene-poor L1-dense domains as a major influence on the ability of Xist-mediated silencing to be propagated in a continuous manner in cis.
Tang
Y Amy
YA
MRC Clinical Sciences Centre, Faculty of Medicine ICSTM, Hammersmith Hospital, London, UK. neil.brockdorff@bioch.ox.ac.uk.
Huntley
Derek
D
Montana
Giovanni
G
Cerase
Andrea
A
Nesterova
Tatyana B
TB
Brockdorff
Neil
N
PLoS Genet. 2006 Sep 29;2(9):e151
17009873
Genet Res. 1974 Jun;23(3):291-306
4435357
Nat Struct Mol Biol. 2006 Sep;13(9):763-71
16936727
Cell. 1992 Oct 30;71(3):527-42
1423611
Nature. 1996 Jan 11;379(6561):131-7
8538762
PLoS Genet. 2008 Aug 29;4(8):e1000172
18769724
Hum Mol Genet. 1999 Feb;8(2):195-204
9931327
Cytogenet Cell Genet. 1983;35(4):279-92
6578005
Cytogenet Cell Genet. 1998;80(1-4):133-7
9678347
J Cell Biol. 2006 Jul 3;174(1):27-38
16818717
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7757-61
2170987
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7706-11
16679409
Hum Mol Genet. 1999 Feb;8(2):377-83
9931347
Hum Mol Genet. 2003 Oct 1;12(19):2559-67
12925568
Genes Dev. 2006 Aug 15;20(16):2223-37
16912274
Nucleic Acids Res. 2003 Feb 15;31(4):e15
12582260
Trends Genet. 2003 Aug;19(8):432-8
12902161
Nucleic Acids Res. 2001 Nov 1;29(21):4493-501
11691937
Hum Mol Genet. 2002 Dec 1;11(25):3157-65
12444100
Chromosoma. 2004 Dec;113(6):324-35
15616869
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6634-9
10841562
Nature. 1997 Mar 20;386(6622):275-9
9069285
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3789-94
9108056
Am J Hum Genet. 1998 Jul;63(1):20-8
9634520
Nature. 2005 Mar 17;434(7031):325-37
15772651
Chromosoma. 2006 Apr;115(2):123-8
16404627
Nature. 2004 May 20;429(6989):268-74
15152245
BMC Bioinformatics. 2008 Nov 27;9:501
19038045
Genes Dev. 1991 Sep;5(9):1513-23
1653172
Mol Cell. 2000 Apr;5(4):695-705
10882105
Nat Genet. 1998 May;19(1):19-24
9590283
Stat Appl Genet Mol Biol. 2004;3:Article3
16646809
Dev Cell. 2009 Apr;16(4):507-16
19386260
Cell. 1992 Oct 30;71(3):515-26
1423610
Proc Natl Acad Sci U S A. 1979 Oct;76(10):5234-8
291940
Science. 1963 May 31;140(3570):976-8
13975649
Annu Rev Genet. 1983;17:155-90
6364959